TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17720111

Group type: EXPERIMENTAL
Intervention: Stimulating catheter (SC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nonstimulating catheter (NSC)
Number of subjects: 70
Study: 15222827

Group type: EXPERIMENTAL
Intervention: Direct observation methods and systematic time sampling
Number of subjects: 177
Study: 11277444

Group type: EXPERIMENTAL
Intervention: Left visual-field (right-hemisphere function)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Hemispheric advantage in perception of happy expression
Number of subjects: 80
Study: 9700280

Group type: EXPERIMENTAL
Intervention: Growth Monitoring Teaching Aid (GMTA) used for 2-4 hours
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 7912725

Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel) at 110 mg/m2 per course
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel)
Number of subjects: 32
Study: 2741669

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: COMPARATOR
Intervention: Urapidil
Number of subjects: 25

Group type: COMPARATOR
Intervention: Trazodone
Number of subjects: 25
Study: 51514

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31222342

Group type: COMPARATOR
Intervention: Methionine supplementation (0, 0.075, 0.15, 0.225, and 0.30%)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Dietary energy level of 12.95 MJ/kg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Methionine supplementation
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Dietary energy level
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Interaction of dietary energy and supplemental Met level
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Methionine requirements at 10.82 MJ/kg ME
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Methionine requirements at 12.95 MJ/kg ME
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Methionine requirements expressed as g/MJ ME of diet
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Methionine requirement differences
Number of subjects: 300
Study: 28416500

Group type: EXPERIMENTAL
Intervention: Enhanced online canteen ordering system with evidence‐based strategies targeting availability, menu labelling, placement and prompting.
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Standard online ordering only (control group).
Number of subjects: 1040
Study: 25893157

Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) program
Number of subjects: 872
Study: 22692114

Group type: EXPERIMENTAL
Intervention: 600 ml of water (W)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salt-water (SW, 40 mM Na)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution with 3% or light carbohydrate (CES-L, 20 mM Na)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution with 6% carbohydrate (CES, 20 mM Na)
Number of subjects: 10
Study: 21757458

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 2553

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2553
Study: 20071896

Group type: EXPERIMENTAL
Intervention: Music therapy and rhythmic exercise (twice a week for 8 weeks)
Number of subjects: 35
Study: 16492702

Group type: EXPERIMENTAL
Intervention: Micronized fenofibrate (267 mg/d)
Number of subjects: 91

Group type: COMPARATOR
Intervention: AHA step 1 diet
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 12837876

Group type: EXPERIMENTAL
Intervention: Propofol/Fentanyl (P/F)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Ketamine/Midazolam (K/M)
Number of subjects: 113
Study: 11146956

Group type: EXPERIMENTAL
Intervention: Continuous blood gas monitoring (CDI 500)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Intermittent blood gas monitoring
Number of subjects: 59
Study: 9022524

Group type: EXPERIMENTAL
Intervention: Aspartame treatment group
Number of subjects: 163

Group type: COMPARATOR
Intervention: No aspartame treatment group
Number of subjects: 163
Study: 11767314

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 67

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 3510822

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 100 micrograms
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 200 micrograms
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 300 micrograms
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (200 micrograms) and fenoterol (400 micrograms) combination
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fenoterol 400 micrograms
Number of subjects: 24
Study: 30710391

Group type: EXPERIMENTAL
Intervention: CEP-26401 (5 μg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CEP-26401 (25 μg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CEP-26401 (125 μg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Modafinil (200 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Donepezil (10 mg)
Number of subjects: 40
Study: 30032977

Group type: EXPERIMENTAL
Intervention: Plasma
Number of subjects: 125

Group type: COMPARATOR
Intervention: Normal Saline (Control)
Number of subjects: 125
Study: 26865535

Group type: EXPERIMENTAL
Intervention: Alogliptin 12.5 mg
Number of subjects: 2639

Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg
Number of subjects: 2639

Group type: COMPARATOR
Intervention: Glipizide (≤20 mg daily)
Number of subjects: 2639
Study: 23586451

Group type: EXPERIMENTAL
Intervention: Reinforcement interventions with two or more job-related activities
Number of subjects: 185

Group type: COMPARATOR
Intervention: Reinforcement interventions with one or no job-related activities
Number of subjects: 185
Study: 22292000

Group type: EXPERIMENTAL
Intervention: High empathy condition (cognitive empathy) while listening to sad operatic content
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: High empathy condition (cognitive empathy) while listening to happy operatic content
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low empathy condition while listening to sad operatic content
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low empathy condition while listening to happy operatic content
Number of subjects: 56
Study: 19091308

Group type: EXPERIMENTAL
Intervention: Positive CBM
Number of subjects: 48

Group type: COMPARATOR
Intervention: Negative CBM
Number of subjects: 48
Study: 17931408

Group type: EXPERIMENTAL
Intervention: Cocaine (0.2 mg/kg) administered under 100% probability ('unblinded')
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cocaine (0.2 mg/kg) administered under 33% probability ('blinded')
Number of subjects: 45
Study: 14598981

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10839761

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment for 3 months
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 9286227

Group type: EXPERIMENTAL
Intervention: Ethanol-containing solution (4% w/v, 4.06 kcal/min, 1190 mosmol/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ethanol-free solution (2.64 kcal/min, 160 mosmol/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ethanol-free hyperosmolar solution (4.06 kcal/min, 1160 mosmol/kg)
Number of subjects: 8
Study: 8450782

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 3766636

Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 82

Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 82
Study: 29747957

Group type: EXPERIMENTAL
Intervention: Print-based intervention
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Move-It intervention
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Move-It plus support intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 52
Study: 27759633

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous fascia iliaca compartment block
Number of subjects: 60
Study: 24800966

Group type: EXPERIMENTAL
Intervention: Web-based guided self-help course (Happy@Work), 6 weekly lessons
Number of subjects: 231

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 231
Study: 22418581

Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated EVD catheters
Number of subjects: 434

Group type: COMPARATOR
Intervention: Standard EVD catheters
Number of subjects: 434
Study: 20598573

Group type: EXPERIMENTAL
Intervention: Proximal valve polyurethane PICC
Number of subjects: 326

Group type: COMPARATOR
Intervention: Distal valve silicone PICC
Number of subjects: 326
Study: 18665068

Group type: COMPARATOR
Intervention: $20 check incentive
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: $50 check incentive
Number of subjects: 578
Study: 15590212

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol therapy (50 microg per day) for 3 months
Number of subjects: 59

Group type: COMPARATOR
Intervention: Untreated arm
Number of subjects: 59
Study: 12895191

Group type: EXPERIMENTAL
Intervention: Olanzapine 2.5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg
Number of subjects: 24
Study: 10100650

Group type: EXPERIMENTAL
Intervention: Single treatment IPL
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Double treatment IPL
Number of subjects: 71
Study: 8728345

Group type: EXPERIMENTAL
Intervention: Intravenous administration of mycophenolate mofetil (1.5 g)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral administration of mycophenolate mofetil (1.5 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both routes (oral and intravenous)
Number of subjects: 12
Study: 2059780

Group type: EXPERIMENTAL
Intervention: Calcium alginate (Kaltostat) dressing
Number of subjects: 46

Group type: COMPARATOR
Intervention: Scarlet red dressing
Number of subjects: 46
Study: 6344625

Group type: EXPERIMENTAL
Intervention: 1,000 mg acetaminophen
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: 650 mg aspirin
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study: 31945052

Group type: EXPERIMENTAL
Intervention: Blood cultures taken
Number of subjects: 2392

Group type: COMPARATOR
Intervention: Missing blood cultures
Number of subjects: 2392
Study: 31184740

Group type: EXPERIMENTAL
Intervention: 30-minute SBT with 8-cm H2O pressure support ventilation (n=557)
Number of subjects: 1153

Group type: COMPARATOR
Intervention: 2-hour T-piece SBT (n=578)
Number of subjects: 1153

Group type: EXPERIMENTAL
Intervention: 30-minute SBT with 8-cm H2O pressure support ventilation
Number of subjects: 1153

Group type: COMPARATOR
Intervention: 2-hour T-piece SBT
Number of subjects: 1153
Study: 29020251

Group type: EXPERIMENTAL
Intervention: Celecoxib (100-200 mg bid)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Ibuprofen (600-800 mg tid)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Naproxen (375-500 mg bid)
Number of subjects: 444
Study: 26895675

Group type: EXPERIMENTAL
Intervention: Closure of mesenteric defects
Number of subjects: 2507

Group type: COMPARATOR
Intervention: Non-closure of mesenteric defects
Number of subjects: 2507
Study: 23932566

Group type: EXPERIMENTAL
Intervention: 5-minute educational intervention
Number of subjects: 479
Study: 23067154

Group type: EXPERIMENTAL
Intervention: Unintended pregnancies
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Induced abortions among unintended pregnancies
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Induced abortions among all pregnancies
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Age less than 35 years
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Less than high school education
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Unemployed
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: More than three children
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Lower income
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: More than three children among women with unintended pregnancy
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Lower income among women with unintended pregnancy
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Age less than 35 years among women with unintended pregnancy
Number of subjects: 1264
Study: 19950736

Group type: EXPERIMENTAL
Intervention: Microcurrent skin patches (two adhesive electrodes)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Continuous epidural infusion with fentanyl (Control Group)
Number of subjects: 28
Study: 17518957

Group type: EXPERIMENTAL
Intervention: Profylin fluoride gel with buffering components
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Profylin fluoride gel without buffering components
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Rinsing with water
Number of subjects: 14
Study: 12695250

Group type: EXPERIMENTAL
Intervention: NEI‐VFQ overall score and subscale scores (near activities, dependency, driving, role difficulties, distance activities, mental health, general vision, peripheral vision, and social functioning)
Number of subjects: 218
Study: 10443767

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1141
Study: 8777886

Group type: EXPERIMENTAL
Intervention: Jet-Cutter
Number of subjects: 60

Group type: COMPARATOR
Intervention: CUSA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 60
Study: 1671885

Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 3161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3161
Study: 6630552

Group type: EXPERIMENTAL
Intervention: WAIS
Number of subjects: 88

Group type: COMPARATOR
Intervention: WAIS-R
Number of subjects: 88
Study: 31177761

Group type: EXPERIMENTAL
Intervention: Mendelian randomization methods applied to blood metabolites
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three methods of Mendelian randomization
Number of subjects: 0
Study: 27618821

Group type: EXPERIMENTAL
Intervention: Genexol-PM 260 mg/m2
Number of subjects: 212

Group type: COMPARATOR
Intervention: Genexol 175 mg/m2
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Genexol-PM
Number of subjects: 212

Group type: COMPARATOR
Intervention: Genexol
Number of subjects: 212
Study: 25839363

Group type: EXPERIMENTAL
Intervention: Patient education materials (leaflet and video)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Communication resource for physicians
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quality of life survey
Number of subjects: 40
Study: 23890047

Group type: EXPERIMENTAL
Intervention: Evening administration of low-dose aspirin
Number of subjects: 258
Study: 21773673

Group type: EXPERIMENTAL
Intervention: Travoprost 0.004%/timolol 0.5% fixed combination (TTFC)
Number of subjects: 105
Study: 19384192

Group type: EXPERIMENTAL
Intervention: Valsartan/HCTZ (160 mg/25 mg, titrated to 320/25 mg)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Amlodipine/HCTZ (5 mg/25 mg, titrated to 10/25 mg)
Number of subjects: 482
Study: 17107398

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus (LGG) 10 x 10^9 colony-forming units daily for 8 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 15902479

Group type: EXPERIMENTAL
Intervention: Drain clamped for 1 hour postoperatively, then kept open for 48 hours.
Number of subjects: 73

Group type: COMPARATOR
Intervention: Drain clamped and released for 10 min every 2 hours for 24 hours.
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 2-hourly clamping of drain and release for 10 min
Number of subjects: 73
Study: 10687944

Group type: EXPERIMENTAL
Intervention: 50 mg PPA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 100 mg PPA
Number of subjects: 15

Group type: COMPARATOR
Intervention: Oxymetazoline nasal spray
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PPA (both doses)
Number of subjects: 15
Study: 8678175

Group type: EXPERIMENTAL
Intervention: 35% CO2 challenge
Number of subjects: 203

Group type: COMPARATOR
Intervention: No reaction to 35% CO2 challenge
Number of subjects: 203
Study: 1884574

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthwash
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Phenolic mouthwash
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline mouthwash
Number of subjects: 15
Study: 6130599

Group type: EXPERIMENTAL
Intervention: Antacid tablets (total acid‐neutralizing capacity, 280 mmol/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Antacid tablets
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 75
Study: 30343455

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Problem solving therapy (PST)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Brief supportive psychotherapy (BSP)
Number of subjects: 134

Group type: COMPARATOR
Intervention: All three therapies
Number of subjects: 134
Study: 29974934

Group type: EXPERIMENTAL
Intervention: alfentanil
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17
Study: 26717498

Group type: EXPERIMENTAL
Intervention: Joint mobilization
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Plantar massage
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Triceps surae stretching
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 24411921

Group type: EXPERIMENTAL
Intervention: Tipifarnib 300 mg orally twice daily on days 1‐21
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Tipifarnib 600 mg orally twice daily on days 1‐21
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Tipifarnib 300 mg orally twice daily on days 1‐7 and 15‐21
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Tipifarnib 600 mg orally twice daily on days 1‐7 and 15‐21
Number of subjects: 348
Study: 23160054

Group type: EXPERIMENTAL
Intervention: School Well-Being Therapy intervention
Number of subjects: 227

Group type: COMPARATOR
Intervention: Attention-placebo
Number of subjects: 227
Study: 20147473

Group type: EXPERIMENTAL
Intervention: MCT:FO
Number of subjects: 12

Group type: COMPARATOR
Intervention: MCT:LCT
Number of subjects: 12
Study: 18510278

Group type: EXPERIMENTAL
Intervention: Increased inspections and surveillance activities (over 350 inspections/year in 250 sites/year)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Implementation of prevention strategies and monitoring of notifications and certificates of work-related injuries
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Sanctions related to high-level work, scaffolding, protection against falls from heights, and Personal Protective Equipment (DPI)
Number of subjects: 600
Study: 15713438

Group type: EXPERIMENTAL
Intervention: Chlorinated solution of neutral red with ultraviolet-A light exposure
Number of subjects: 0
Study: 12589898

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychological treatments for prodromal symptoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11149790

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg) preoperatively
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg) postoperatively
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg) preoperatively or postoperatively
Number of subjects: 55
Study: 7488578

Group type: EXPERIMENTAL
Intervention: Argon green laser photocoagulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 20
Study: 2024569

Group type: EXPERIMENTAL
Intervention: Conventional chest physiotherapy alone (PHYS)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Chest physiotherapy and positive expiratory pressure (PEP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Chest physiotherapy with both positive expiratory pressure and inspiratory resistance (RMT)
Number of subjects: 51
Study: 30715452

Group type: EXPERIMENTAL
Intervention: 2 doses of AS04-adjuvanted HPV-16/18 vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 doses of AS04-adjuvanted HPV-16/18 vaccine
Number of subjects: 0
Study: 27757820

Group type: EXPERIMENTAL
Intervention: REHACOP group (cognitive rehabilitation)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (occupational therapy)
Number of subjects: 44
Study: 25308787

Group type: EXPERIMENTAL
Intervention: Biweekly induction with intravitreal bevacizumab (every 2 weeks for 3 consecutive injections)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Monthly induction with intravitreal bevacizumab (every 4 weeks for 3 consecutive injections)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Immediate pro re nata (prn) after the first injection
Number of subjects: 90
Study: 24180715

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA) using propofol plus remifentanil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Volatile induction/maintenance of anaesthesia (VIMA) using sevoflurane
Number of subjects: 50
Study: 21694537

Group type: EXPERIMENTAL
Intervention: 500 U lipase/kg/meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1000 U lipase/kg/meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1500 U lipase/kg/meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2000 U lipase/kg/meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 16
Study: 19023899

Group type: EXPERIMENTAL
Intervention: Scheduled maintenance therapy (group A) - IFX every 2 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: On demand maintenance therapy (group B) - IFX on relapse
Number of subjects: 40